2000
Briefing Serves as a Call to Action to Address Significant Health Concern Indianapolis, IN - In an effort to provide increased visibility to a growing public health crisis-cardiovascular disease...
Data from INHIBIT Trial Shows In-Stent Restenosis Reduction With Radiotherapy Indianapolis, Ind. and Santa Clara, Calif. - Results from the INHIBIT (INtimal Hyperplasia Inhibition with Beta...
Landmark Study Examines Minimally Invasive Alternative for Treating Carotid Artery Disease Indianapolis, Ind., Santa Clara, Calif. and Newark, N.J. - Guidant Corporation (NYSE and PCX: GDT) and...
Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary artery disease, announced today that is has filed with the U.S....
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a global leader in the development of medical technology for the treatment of cardiovascular and vascular disease, today announced...
Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a worldwide leader in cardiovascular technologies that save and improve lives, today announced that it has received...
Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary artery disease, today announced the enrollment of the first...
Indianapolis, IN and Menlo Park, CA - Two years of clinical data demonstrate that Guidant Corporation''s (NYSE and PCX: GDT) ANCURE(tm) Bifurcated Endograft System is an effective and safe,...
Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT) today announced that on October 1, 2000 John C. Jenkins will become Vice President and General Counsel of the company, reporting to...
Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in the medical technology industry, commends President Clinton''s Executive Memorandum taking the first step toward...
Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world-leader in the treatment of cardiovascular disease, announced today that it has agreed with Boston Scientific Corporation on a...
Indianapolis, IN and Santa Clara, CA - Guidant Corporation (NYSE and PCX: GDT), a global leader in the development of technologies for the treatment of carotid artery and peripheral vascular...
MULTI-LINK TETRA Coronary Stent System Receives CE Mark Approval Indianapolis, IN and Santa Clara, CA - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary artery...
Indianapolis, IN and Santa Clara, CA - Patients suffering from re-occurring blockages in coronary arteries can now look forward to a new technology that has been shown to reduce the recurrence of...
Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a worldwide leader in implantable medical device systems, today announced the start of PACMAN, a multicenter European...
Indianapolis, IN and Santa Clara, CA - Guidant Corporation (NYSE and PCX: GDT) a world leader in the treatment of coronary artery disease, today announced the launch of a new coronary dilatation...
Indianapolis, IN, and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a worldwide leader in cardiac rhythm management systems, today announced that the FDA has approved the DISCOVERY(tm)...
Move Strategically Prepares Company for Future Global Opportunities INDIANAPOLIS, IN - Guidant Corporation (NYSE and PCX: GDT) today announced that it has created an Office of the President to...
Ronald W. Dollens Assumes Additional Operational Duties INDIANAPOLIS, IN - Guidant Corporation (NYSE and PCX: GDT) announced today that James M. Cornelius, currently Chairman of the Guidant Board...
Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a worldwide leader in implantable medical device systems, today announced the start of COMPANION, a multicenter...
Indianapolis, IN and Santa Clara, CA - Guidant Corporation (NYSE and PCX: GDT), a worldwide leader in the treatment of coronary artery disease, today announced that it has begun initial clinical...
Indianapolis, IN, and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a worldwide leader in implantable defibrillation systems, today announced the company has received FDA approval to...
Indianapolis, IN, and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a worldwide leader in cardiac rhythm management systems, today announced the European market release of the next...